Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
02 Août 2024 - 3:00PM
Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune
testing solutions, today announced its participation in the
Canaccord Genuity 44th Annual Growth Conference, which takes place
August 13-15, 2024, at the InterContinental Boston Hotel in Boston,
MA. John Aballi, Exagen’s President and Chief Executive Officer
will participate in a fireside chat on Wednesday, August 14th, at
2:30 PM ET. Interested parties may access the webcast of the
presentation using a link on Exagen’s website at
https://investors.exagen.com/events.
About Exagen Inc.
Exagen is a leading provider of autoimmune testing and its
purpose as an organization is to provide clarity in autoimmune
disease decision making with the goal of improving patients’
clinical outcomes. Exagen is located in San Diego County,
California.
For more information, please visit Exagen.com or follow
@ExagenInc on X (formerly known as Twitter).
Contact:Ryan DouglasExagen
Inc.ir@exagen.com760.560.1525
Exagen (NASDAQ:XGN)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Exagen (NASDAQ:XGN)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
